Ionis Pharmaceuticals Inc. News
Will uniQure Solve a Key Huntington's Disease Riddle?
Many companies are taking a similar approach, but no one is quite sure if it'll help patients.
Cathie Wood Watch: Ark Buys Healthcare/Tech Stocks
The return of Wood's flagship Ark Innovation ETF lagged behind the S&P 500 for the five years through July 5.
Alnylam's 5th Drug Launches in July, Disrupting Commercial Landscape
A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.
Cathie Wood Watch: Ark Piles Into Nvidia, Buys an AI Biotech
Ark Innovation has dropped 54% this year but has enjoyed inflow of $1.2 billion over the past six months.
Cathie Wood Watch: Ark Reverses Course on Electric-Vehicle Titan Tesla
Asset manager Cathie Wood also bought shares of her flagship fund's No. 3 holding and shares of a cryptocurrency exchange.
MercadoLibre, Sabre Make Morningstar List of Undervalued Stocks
The list includes stocks that beat first-quarter-earnings estimates by more than 10% and garnered moats from Morningstar analysts.
Biogen's ALS Drug Won't Move Forward After Trial Failures
Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.
Cramer's Mad Money Recap 3/24: Intel, Marvell, Nvidia
Jim Cramer says fund managers are looking for stocks that have been beaten down big, but still represent value.
Stocks End Mixed as Strong Earnings Offset Weak China GDP
Apple debuts latest Mac Book Pro; Zillow zapped as house purchases paused.
Home Depot Blasts Q2 Earnings Forecasts Amid Home Improvement Surge
"In the second quarter, we delivered the highest quarterly sales and earnings in our company's history," said CEO Ted Decker. "Our performance reflects continued strength in demand for home improvement projects."
We're Enduring 'Housing Recession,' Homebuilders' Economist Says
The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.